Advances in the adjuvant and neoadjuvant treatment of breast cancer

被引：1

作者：

Briest, Susanne ^{[1
,2
]}

Stearns, Vered ^{[2
]}

机构：

[1] Univ Leipzig, Dept Gynecol & Obstet, Leipzig, Germany

[2] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,CRB 1,Room 1M-53, Baltimore, MD 21231 USA

来源：

WOMENS HEALTH | 2007年 / 3卷 / 03期

关键词：

adjuvant treatment; aromatase inhibitors; breast cancer; chemotherapy; hormonal therapy; neoadjuvant treatment; trastuzumab;

D O I：

10.2217/17455057.3.3.325

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Several advances in the adjuvant systemic therapy of primary breast cancer have occurred in the last decade and contributed to a decline in disease-related mortality. These include the introduction of aromatase inhibitors, new chemotherapy agents, and the novel antibody trastuzumab. New supportive treatments, such as growth factors, have contributed to the optimization of chemotherapy dose and schedule, and have improved the efficacy and safety of the treatment. In this review we will outline some of the recent advances in the adjuvant and neoadjuvant treatment of breast cancer. We will also discuss ongoing and proposed clinical trials.

引用

页码：325 / 339

页数：15

共 50 条

[21] Neoadjuvant treatment in breast cancer. Role of the pathologist [J].

Burgues, Octavio ;

Terradez, Liria ;

Buch, Elvira ;

Teresa Martinez, Ma ;

Miguel Cejalvo, Juan ;

Bermejo, Begona .

REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2022, 35 :S87-S100

[22] Post-Neoadjuvant Treatment Strategies in Breast Cancer [J].

Matuschek, Christiane ;

Jazmati, Danny ;

Boelke, Edwin ;

Tamaskovics, Balint ;

Corradini, Stefanie ;

Budach, Wilfried ;

Krug, David ;

Mohrmann, Svjetlana ;

Ruckhaeberle, Eugen ;

Fehm, Tanja ;

Nestle Kraemling, Carolin ;

Dommach, Markus ;

Haussmann, Jan .

CANCERS, 2022, 14 (05)

[23] RECENT ADVANCES IN THE TREATMENT OF BREAST-CANCER [J].

ZIEGLER, LD ;

BUZDAR, AU .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1991, 301 (05) :337-352

[24] Neoadjuvant treatment with taxanes in breast cancer [J].

von Minckwitz, Gunter .

BREAST CARE, 2006, 1 (03) :176-184

[25] Neoadjuvant Systemic Treatment of Breast Cancer [J].

Makhoul, Issam ;

Kiwan, Elias .

JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (04) :348-357

[26] ENDOCRINE THERAPY IN BREAST CANCER: THE NEOADJUVANT, ADJUVANT, AND METASTATIC APPROACH [J].

Reinbolt, Raquel E. ;

Mangini, Neha ;

Hill, Jordan L. ;

Levine, Lauren B. ;

Dempsey, Jessica L. ;

Singaravelu, Janani ;

Koehler, Kevin A. ;

Talley, Allison ;

Lustberg, Maryam B. .

SEMINARS IN ONCOLOGY NURSING, 2015, 31 (02) :146-155

[27] Emergence of nonanthracycline regimens in the adjuvant treatment of breast cancer [J].

Pal, Sumanta K. ;

Childs, Barrett H. ;

Pegram, Mark .

BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) :25-32

[28] Neoadjuvant Chemotherapy in the Treatment of Breast Cancer [J].

Redden, Meredith H. ;

Fuhrman, George M. .

SURGICAL CLINICS OF NORTH AMERICA, 2013, 93 (02) :493-+

[29] METFORMIN AS ADJUVANT OPTION FOR SYSTEMIC TREATMENT OF BREAST CANCER [J].

Avierin, D. I. ;

Zavizion, V. F. .

MEDICNI PERSPEKTIVI, 2023, 28 (04) :87-96

[30] Update on adjuvant hormonal treatment of early breast cancer [J].

Romera J.L. ;

Hernández T.J.P. ;

Fernández I.P. ;

Gimeno T.S. ;

Martínez R.F. ;

Pérez I.F. ;

Cruz V.I.G. ;

Manas J.J.I. ;

Juan S.G. ;

Gil E.M.C. .

Advances in Therapy, 2011, 28 (Suppl 6) :1-18

← 1 2 3 4 5 →